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Abstract
Microbiological culture is the conventional method for establishing the diagnosis in implant-associated bone and joint infection, but it may
lack both specificity and sensitivity. Molecular diagnosis has been an important step in the diagnosis of infectious diseases. We review the
principles and the role of molecular diagnosis in improving the aetiological diagnosis of implant-associated bone and joint infection. Cur-
rently, molecular diagnosis mainly includes conventional broad-range PCR and specific PCR assays. These tools are efficient, but several
pitfalls exist that necessitate rigour in all steps of the process. In implant-associated bone and joint infection, molecular assays have been
shown to be useful in complementing culture techniques to identify microorganisms when patients have previously received antibiotics or
in the presence of fastidious microorganisms. Broad-range PCR targeting the 16S rRNA sequence followed by sequencing must be per-
formed in culture-negative specimens when infection is suspected on the basis of clinical signs and symptoms or inflammatory syndrome.
This molecular tool has allowed not only increasing identification of anaerobic bacteria, such as Finegoldia magna, but also the discovery
of the role of Tropheryma whipplei, an aetiological agent of implant-associated bone and joint infection in patients without Whipple’s dis-
ease. Real-time pathogen-specific PCR assays performed in a closed system are more sensitive and specific than broad-range PCR, but
each assay is typically able to detect only a single microorganism. These assays should be performed to confirm the identification pro-
vided by broad-spectrum PCR, and also when broad-range PCR fails to detect a microorganism despite efficient DNA extraction.
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Introduction
The diagnosis and treatment of implant-associated bone and
joint infection is a major challenge [1]. These infections are
mainly caused by microorganisms that grow in biofilms on the
surface of the implant [1]. In the biofilm, microorganisms are
difficult to diagnose and treat effectively. Indeed, they are
recalcitrant to conventional antimicrobial agents and host
immune responses [1]. The failure of aetiological diagnosis
with traditional culture may be caused by prior antimicrobial
exposure and fastidious microorganisms, but it is also possibly
related to the reduced growth rate of biofilm microorganisms
delaying or inhibiting growth in microbiological culture [1,2].
In culture-negative cases, treatment is performed on an
empirical basis, with poor prognosis [1,3]. Molecular tools
may help to establish an aetiological diagnosis, but molecular
procedures must be rigorously performed because of the
risks of interfering contamination [4]. The efficiency of PCR
assays in detecting microorganisms depends on sample col-
lection, PCR methodology, validation, and the interpretation
of each PCR analysis [5]. Basic rules must be applied to
obtain reliable results. In this article, we review the entire
process of performing and interpreting molecular amplification
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assays, and their role in the diagnosis of implant-associated
bone and joint infections.
Clinical Samples for PCR Assays
Collection
PCR assays should be performed on fluids collected by nee-
dle aspiration or on periprosthetic tissues obtained by surgi-
cal biopsy [5]. At least three specimens should be sampled
for culture [3,6–8]. They should be shipped immediately to
the laboratory after collection [5]. Prior to culture, a piece
of each specimen should be stored at )20C or )80C for
further analyses [5,9]. If fresh specimens are not available,
PCR could be performed on paraffin-embedded biopsy speci-
mens, but this alternative lacks both sensitivity and specificity
[10]. Superficial wounds should be avoided, because of the
frequent colonization by microbial flora from the surround-
ing skin [11]. Samples collected by swab should be avoided,
as they may lack sensitivity [3]. The application to the speci-
mens of an appropriate sonication technique with an ultra-
sound bath has recently shown encouraging results [12].
DNA extraction
Prior to molecular amplification, DNA extraction is an
important step. Various protocols have been reported
[5,9,13–16]. To optimize the quality of the DNA extracts, an
overnight step in lysis buffer and proteinase K before extrac-
tion is strongly advised for bone and joint specimens, includ-
ing fluids. Moreover, the use of automation, which allows
the elimination of several manual steps and the risk of cross-
contamination, should be preferred.
Interpretation of PCR Assays
PCR pitfalls and solutions
There is sometimes a lack of efficient DNA extraction, lead-
ing to false-negative results. The main critical points are the
technique used and the cell wall of the bacteria [17]. The
quality of DNA extracts must be evaluated by amplifying a
fragment of a human gene, such as the b-globin or actin gene
[5,9]. In cases of negativity, another specimen must be
extracted at another time. The amount of background DNA
from bacteria and the size and abundance of the amplified
fragment may also play a role [17,18]. When possible, a
short target (c. 100 bp) should be designed [18].
Molecular assays are also prone to contamination, which
can occur from the time when the samples are obtained to
their manipulation during the laboratory process [4,19]. Con-
tamination may occur from one sample to another during
the assay, or from laboratory surfaces, tubes, pipettes, the
technician’s hair or clothes, or previous amplicons in the lab-
oratory. Even if those risks can be lowered by following
strict rules, single-use plasticware, tubes, water and reagents
can still be a source of contamination [4,20,21]. Thus, it is
imperative to carefully follow standard recommendations to
prevent contamination (Fig. 1) [5,21,22].
Validation
The presence of positive and negative controls in each PCR
assay is necessary to validate the assay. The use of positive
controls (extracted bacterial DNA) allows confirmation that
the PCR process was correct. DNA from a microorganism
that does not commonly cause implant-associated bone and
joint infection, such as Escherichia coli, is preferred to DNA
from a common causative pathogen. The use of negative
controls, processed from DNA extraction to PCR in parallel
with the tested samples, is imperative to detect contamina-
tion. Water, a mixture of all reagents used in the PCR assay
and DNA extracted from human tissue without infection can
be used as negative controls [19].
Interpretation
Both negative and positive controls must be correct for
interpretation of the PCR. If the positive control was not
detected or if any amplification of the negative control
occurred, the run is unreliable [23] and should be repeated.
For broad-range PCR, each positive amplicon must be
sequenced for accurate identification of the causative micro-
organism. An original sequence observed for the first time in
a laboratory can usually be considered to be a true positive
[10]. A similar sequence found in the same run from samples
of two patients suggests potential contamination. Sequences
from microorganisms that are commonly present in water
or reagents (Pseudomonas spp. and Acinetobacter spp.) and
those from microorganisms from skin (coagulase-negative
staphylococci and Propionibacterium acnes) may result from
contamination. The interpretation of the results is sometimes
difficult, as coagulase-negative staphylococci are the most
commonly observed pathogens in implant-associated infec-
tions. Thus, the microorganisms of the normal skin flora may
be either contaminants or pathogens. If a result is doubtful
or has a low predictive value, supportive data can help in the
interpretation. PCR targeting a second gene can be per-
formed with the same DNA extract, and another sample of
the patient can be extracted and tested at another time.
Finally, the persistence of DNA from the causative agent
has been reported in infective endocarditis from months to
years after clinical cure. It is possible that, as with endocarditis,
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the link between the current episode and the amplified DNA
needs to be evaluated for implant-associated bone and joint
infections [24,25]. However, to the best of our knowledge,
there are currently no published data on this potential diag-
nostic problem.
Usefulness of PCR Assays
The main indication for PCR assays is the lack of microor-
ganism culture. No microorganisms are detected in approxi-
mately 5–15% of apparent infections [1]. However, suspicion
of mixed infections, mainly in the case of open lesions, can
be also an indication.
Fastidious microorganisms
Molecular diagnosis has allowed spectacular data to be
obtained for the identification of Kingella kingae among chil-
dren with osteoarticular infections [13,15,26]. Currently, for
patients with implant-associated bone and joint infections,
PCR assays have mainly allowed the identification of Granulica-
tella spp., Staphylococcus aureus, even in cases of small-colony
variant infection, and anaerobic bacteria [1,27]. Indeed, the
implication of Finegoldia magna as a pathogen in prosthetic
joint infection has been rediscovered by broad-spectrum PCR
[28,29]. PCR has also allowed the establishment of the role of
Tropheryma whipplei as an aetiological agent of prosthetic joint
infection without other classic signs of Whipple’s disease [30–
32]. More recently, Legionella micadadei has been reported to
cause prosthetic joint infection, thanks to the systematic use
of 16S rRNA PCR [33]. PCR could also help in the diagnosis
of other fastidious microorganisms involved in implant-associ-
ated bone and joint infections, such as Mycobacterium tuberculo-
sis or other Mycobacterium spp. [34–36].Thus, broad-spectrum
PCR is useful in the diagnosis of difficult-to-culture organisms,
especially when the pathogen is rare or unsuspected.
Previous antibiotic therapy
Antimicrobial therapy must be discontinued at least 2 weeks
before the sampling of specimens [1]. In cases of revision sur-
gery, perioperative prophylaxis must not be administered until
after tissue specimens have been collected. However, in cases
of a longer duration of antibiotic therapy or inadequate pro-
phylaxis, broad-range PCR may help to establish an aetiological
diagnosis [5,22,37].
Mixed infection
The potential inability of broad-range PCR to identify a mix-
ture of bacterial species in a single specimen has been con-
sidered [38]. However, 16S rRNA PCR combined with
Prevention
-Limit access to the laboratory to the authorized personnel 
-Educate and train the laboratory personnel on the molecular biology rules
-Supervise the strict application of the rules by the laboratory personnel
-Encourage communication among personnel of laboratories about a potential risk of 
contamination and about suspected contamination
Detection
-Run negative control for 5 to 10 samples
Neighbouring contamination
Water and reagent contamination
Prevention
-Prepare aliquots of mixture with primers and eventually probes
-Digest with restriction enzymes 
Detection
-Use mix as negative control
-Confirm PCR with a second target
Horizontal contamination (carryover)
Prevention
-Perform DNA extraction on an automate
-Perform PCR in a closed system
-Use a bacterium that is not a usual pathogen as a positive control
Detection
-Run negative control for 5 to 10 samples
-Sequence all positive amplicons
Prevention
-Wear gloves, caps and coats
-Use separate, dedicated and controlled rooms
-Disinfect working surfaces after each run with a bleach solution
-Use UV light to irradiate pipettes and working surfaces
-Use of uracil-DNA-glycosylase/dUTP 
-PCR performed in closed system
Detection
-Run one negative control for 5 to 10 samples
Vertical contamination (previous amplification)






FIG. 1. The most frequent contamination pitfalls and the solutions for their prevention and detection.
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cloning is able to detect mixed polymicrobial infections,
allowing for identification of the main bacteria present in the
mixture [5]. Moreover, with this approach, new potential
microorganisms have been reported among patients with
mixed infections, whereas no novel bacterial species were
detected in monobacterial specimens [5]. These unusual
microorganisms are not detected in culture, mainly because
of overgrowth by rapidly growing species.
Conventional Broad-range PCR
Methodology
The 16S rRNA gene, the 23S rRNA gene, the rpoB gene and
the 16S–23S intergenic spacer are present in all bacteria, and
are thus particularly suitable for broad-range PCR [19]. Sev-
eral protocols have been reported for 16S rRNA gene-based
detection of bacteria [16,19,39–41]. However, only 16S
rDNA amplification, systematically followed, when positive,
by sequencing [5], allows accurate identification of the
involved microorganisms, and must be used (Fig. 2). More-
over, nested or semi-nested PCRs that correspond to the
reamplification of a PCR product must be avoided, owing to
the high risk of contamination [32,42]. A polymicrobial infec-
tion must be suspected if a mixed sequence is observed on
the DNA pherogram, and a cloning step with commercialized
kits should be performed [10]. Sequencing of all of the
clones is time-consuming, but it may help to identify new
pathogens. Indeed, a sequence similarity of <97% of the 16S
rRNA sequence is the criterion used to define a potentially
new bacterial species [43–45]. The main primers that have
been published for the diagnosis of implant-associated bone
and joint infections are summarized in Table 1 [5,9].
Limits of conventional broad-range PCR
Although most studies agree about the good specificity of
broad-range PCR in the diagnosis of implant-associated bone
and joint infections, discrepancies have been reported about
its sensitivity, with several studies showing poor sensitivity
(<50%) [5,9,40,46–48]. Several biases could have influenced
these data, such as the lack of pretreatment prior to DNA
extraction, the lack of control of the extracted DNA quality,
or the small number of studied patients [49]. Among the three
studies that have involved more than 50 patients, the sensitiv-
ity of 16S rRNA PCR for osteoarticular infections (both pros-
thetic and not) was determined to be 92.5% vs. 89% for
culture [5] in the first study. The second study reported a
PCR sensitivity of 73.3% (53.8% for prosthetic joint infections
and 88.2% for infections without prostheses), whereas for cul-
tures, the sensitivity was 96.7% [9]. In the third study on pros-
thetic joint infections, culture and PCR had similar sensitivities
(72.6% and 70.4%) and specificities (98.3% and 97.8%) [22].
DNA extraction
Conventional broad-range PCR
16S rRNA PCR (target universally present in bacteria)
Amplification and visualization
of amplified products on agarose gels 
Sequencing of the amplified product
Analysis and comparison of the obtained sequence
with a database containing all known bacterial sequences
Fluids or periprosthetic tissues
Overnight pretreatment in proteinase K and lysis buffer 
Specific PCR assays
Amplification in a closed system
24 h
20 min3 h
At least 1 h
1 h
Clear pherogram Identification of 
a unique bacterium
Polymicrobial infection 
requiring a cloning step
Mixed pherogram
Identification with fluorescent specific DNA probe
YesNo
End of the process
Typically able to detect only a single microorganism
FIG. 2. Methodology of conventional broad-range PCR and specific PCR assays.
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Specific PCR assays
For pathogen-specific PCR, the assays should be performed
with quantitative real-time PCR in a closed system, in which
not only the amplification but also the identification of ampli-
fied products with DNA probes with specific annealing
within the target-amplified region are coupled in a single ves-
sel, reducing the risk of contamination (Fig. 2) [10]. If fluo-
rescence-labelled oligonucleotide hybridization probes are
not used, the identification must be confirmed by sequencing
when an amplified product is detected. Overall, this tech-
nique has other advantages over conventional PCR, including
speed, simplicity, reproducibility, and quantitative capacity.
Pathogen-specific PCR has previously been shown to be
more sensitive than 16S rDNA PCR in osteoarticular infec-
tions for S. aureus and M. tuberculosis [5,50]. Moreover, all of
the currently available sequenced bacterial genomes (2848)
allowed for the best DNA targets to be chosen for specific
assays, with greater sensitivity than that of broad-range PCR
[20]. Thus, pathogen-specific PCR is useful not only when a
more sensitive diagnosis is needed, but also to confirm the
results obtained with broad-range PCR [5].
Strategy for the use of PCR Assays
PCR assays offer several advantages in the diagnosis of
implant-associated bone and joint infection, but its use
should be restricted, as proposed in Fig. 3. Indeed, PCR
assays should be limited to culture-negative cases when
infection is suspected on the basis of clinical signs and symp-
toms or inflammatory syndrome is present, as highlighted by
blood test results and purulent samples [1]. Thus, broad-
range 16S rDNA PCR must be performed when the culture
was not positive. In suspected polymicrobial infections (open
lesion, two or more bacterial species isolated with culture,
and mixed sequence on the DNA pherogram), a 16S rDNA
PCR assay followed by cloning procedures may also be per-
formed. Specific PCR assays should be performed to confirm
the results of broad-range PCR, and also when broad-range
PCR fails to detect a microorganism despite efficient DNA
extraction. The main epidemiological and clinical criteria for
guiding the choice of specific PCR assays to be performed in
a given patient are summarized in Table 2 [1,51–54]. S. aur-
eus-specific PCR assays could also be performed in parallel
with broad-range PCR, because this bacterium is one of the
most common microorganisms associated with prosthetic
joint infections [3].
Antibiotic Therapy Prescription Based on
PCR Results
Among the drawbacks of molecular diagnosis is the lack of
antibiotic susceptibility results (except for specific resistance
genes, such as the genes conferring resistance to methicillin,
quinolones, and rifampicin) [12,49,55,56]. However, when rig-
orously used, molecular tools provide robust diagnoses and
provide indications for the prescription of the best empirical
TABLE 1. Main primers that have been used and published for molecular amplification in implant-associated bone and joint
infections (extract from Table 1 of Fenollar F, Levy PY, Raoult D. Usefulness of broad-range PCR for the diagnosis of osteoar-
ticular infections. Curr Opin Rheumatol 2008; 20: 463–470)
References Microorganisms
Targeted
sequences Forward primer: name and sequence (5¢–3¢) Reverse primer: name and sequence (5¢–3¢)
Fenollar
et al. [5]
Eubacteria 16S rRNA 536F, CAGCAGCCGCGGTAATAC rp2, ACGGCTACCTTGTTACGACTT
Fihman
et al. [9]
Eubacteria 16S rRNA 536f, CAGCAGCCGCGGTAATAC 1050r, CACGAGCTGACGACA
Eubacteria 16S rRNA 16S-241bp-F, GGAGGAAGGTGGGGATGACG 16S-241bp-R, ATGGTGTGACGGGCGGTGTG
Eubacteria 16S rRNA 16S-cons-F, YGGCGRACGGGTGAGTAA 16S-GP-R, CCGATCACCCTCTCAGGTCG for GP
and
16S-GN-R, AGTTAGCCGGTGCTTCTTCT for GN
Fenollar
et al. [5]
Staphylococcus aureus RpoB Saur.Rpob.F, GTTTGAATTGCATGGTAGCGT SaurRpob.R, GAAGCAATGATATCTGCTGGTG
Streptococcus group B RpoB SagaRpob.F, CAATTGCAGAGCATATCGATGG SagaRpob.R, TCCAACAATAGTAACAACACGG
Streptococcus pneumoniae RpoB SpncuRpob.F, GGTAGAAGCTGGTACGATTATGAC SpneuRpob.R, GATCAGTTGGAGCAACAACCT
Enterococcus spp. RpoB StrpF, AARYTIGGMCCTGAAGAAAT StrpR, TGIARTTTRTCATCAACCATGTG
Granulicatella adiacens RpoB GadiaRpob.F, TGTAACTCTAACACTTGTCCGA GadiaRpob.R, GGACGTCACGGTAATAAAGGG
Staphylococcus epidermidis RpoB SepiRpob.F, GTGATACGTCCATGTAATCCA SepiRpob.R, TTTGACAGCTGATGAAGAGGA
Enterobacteriaceae RpoB CM7, AACCAGTTCCGCGTTGGCCTGG CM31b, CCTGAACAACACGCTCGGA
Escherichia coli RpoB EcolRpob.F 5¢-TTCACCAACGATCTGGATCAC EcolRpob.R 5¢-GAAGAACAGGTTCTCGAACAG
Pseudomonas aeruginosa RpoB PaerRpob.F, TGTACACCAACGACATCGAC PaerRpob.R, AAGAACAGGTTGCCGAACAG
Clostridium perfringens Eabcc CloPerF, GACACATTAGTTGGGAAGTG CloPerR, GTTGTTAACCAATGAGCAGC
Propionibacterium acnes 16S–23S rRNA PacnF, CTAAGGAGTTTTTGTGAGTGG PacnR, CTTTGCACAACACCACGTC
Prevotella spp. CfxA2-like
lactamase
PrevoF, GGATAAACTTGACCCAAAGAC PrevoR, GATGTATAGTTAGAGTAAGCC
Y = T or C; R = G or A; K = G or T.
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antibiotic treatment for the identified microorganisms, or
specific treatment in cases when M. tuberculosis, Brucella spp.
or T. whipplei infections are diagnosed [1,30]. If physicians are
faced with a doubtful result and are hesitant to initiate treat-
ment, they must contact their laboratory to discuss the result
and to check the need to confirm its accuracy.
Conclusion and Perspectives
Conventional broad-range PCR has been an important
advance in the diagnosis of infectious diseases. For implant-
associated bone and joint infections, broad-range PCR fol-
lowed by sequencing should not be performed in routine
cases, but to complement culture, mainly for culture-negative
cases, when infection is suspected. In addition to broad-range
PCR, pathogen-specific real-time PCR is also useful. The
technical procedures of PCR assays must be strictly per-
formed, and the interpretation of the results must be rigor-
ous. Even if the antimicrobial susceptibility is not available,
the PCR result orients physicians towards the best empirical
strategy. Molecular assays represent an additional tool with
which to improve the diagnosis of implant-associated bone










Negative after 6 days
Polymorphonuclear leukocytes on Gram staining
and/or 
Increase of the C-reactive protein level1
and/or 
Antibiotic activity in the sample
16S rRNA PCR2
If negative
At least 3 specimens (biopsy, body fluid) 
Congelation for further analysis
If positive (mainly for potential contaminant Staphylococcus epidermidis,
Propionibacterium acnes) Check in the same specimen with a PCR
targeting another gene
or 
Check in another specimenHuman gene PCR Pathogen-specific PCR
Staphylococcus aureus3
Depending on epidemiological/clinical criteria:
See Table 2If negative
Re-extraction of another specimen
If  open lesions
For each specimen
1on serial postoperative analyses
2performed first in one specimen
3could be also performed in parallel with 16S rRNA PCR
FIG. 3. Suggested strategy for the management of specimens in the microbiological laboratory and the use of molecular diagnostics in implant-
associated bone and joint infection.
TABLE 2. Main relevant epidemio-
logical and clinical information for
guiding the choice of specific PCR
assays to be performed in a given
patient with implant-associated
bone and joint infection
Epidemiological and clinical criteria Specific PCR assays
A stay in an endemic area and ingestion of unpasteurized dairy products [54] Brucella melitensis
Children aged <5 years [13] Kingella kingae
Rheumatoid arthritis, chronic steroid use, treatment with monoclonal antibody against
tumour necrosis factor-a, history of Mycobacterium tuberculosis infection involving
another system, and pulmonary diseases [52]
M. tuberculosis
Delayed infectiona, especially in patients with shoulder prostheses [1,53] Propionibacterium acnes
Rheumatoid arthritis, early and acute haematogenous infectionb [1,51] Staphylococcus aureus
Delayed infectionb [1] Staphylococcus epidermidis
aThe usual manifestations of delayed infections (3–24 months after surgery) are subtle, with persistent joint pain and/
or implant loosening.
bThe usual manifestations of early infections (<3 months after surgery) are acute, with joint pain and fever as well as
effusion, redness and warmth at the surgical site.
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teamwork. Indeed, physicians and microbiologists must inter-
act, mainly for low predictive value results.
In the future, with the availability of a large number of
complete bacterial genomes, specific primer sets and probes
targeting a larger spectrum of bacteria could be developed,
allowing for accurate and fast aetiological diagnosis. Multiplex
PCR assays may also improve diagnosis [12]. The potential
role of fluorescence in situ hybridization, a molecular tech-
nique that uses fluorescently labelled probes to detect RNA
or DNA, and that is already used in infective endocarditis,
remains to be evaluated for implant-associated bone and
joint infections [17]. Currently, molecular diagnosis cannot
be performed routinely in every laboratory. However, the
rapid evolution and improvement of the technology could
allow procedure standardization with automated worksta-
tions to perform sample processing, analysis, and product
detection, to open these techniques to wider application in
many laboratories. Molecular diagnosis is a more expensive
diagnostic method than bacterial culture. However, the cost-
effectiveness of this strategy has not yet been evaluated.
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